Abilify MyCite adds a digital sensor to the medication aripiprazole. The sensor, an ingestible event marker, is activated by contact with stomach acids and transmits a signal to a skin patch the patient wears, which then transmits to an app.

Stigma and harassment in a medical setting are not uncommon in the 1.4 million Americans who identify as transgender or gender-nonconforming. It's time for healthcare providers to change the status quo.